Related Experiment Video
Updated: Dec 22, 2025

07:44
CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
Published on: September 14, 2019
8.7K
[CRISPR-Cas9 for muscle dystrophies]
Océane Ballouhey1, Marc Bartoli1, Nicolas Levy2
1Aix Marseille Univ, Inserm, MMG, U1251, 13005 Marseille, France.
Summary
CRISPR-Cas9 gene editing offers a promising permanent solution for genetic muscular dystrophies. This advanced therapy aims to correct gene mutations, potentially overcoming limitations of current treatments for these rare muscle disorders.
Area of Science:
- Genetics
- Molecular Biology
- Neurology
Background:
- Muscular dystrophies are rare genetic disorders causing progressive muscle degeneration.
- Current biotherapies offer limited efficacy and require repetitive treatments.
- Genetic origin necessitates precise therapeutic interventions.
Purpose of the Study:
- To review the latest therapeutic advances in genetic muscular dystrophies using CRISPR-Cas9.
- To highlight the potential of CRISPR-Cas9 for permanent genetic correction.
- To discuss the advantages of CRISPR-Cas9 over existing treatments.
Main Methods:
- Review of studies utilizing the CRISPR-Cas9 genomic editing tool.
- Analysis of CRISPR-Cas9 applications in genetic muscular dystrophies.
- Synthesis of recent research on gene editing for muscle disorders.
Main Results:
- CRISPR-Cas9 enables stable and permanent genome editing.
- Significant and promising advances have been achieved in treating muscular dystrophies.
- Potential to avoid long, partially effective, and repetitive treatments.
Conclusions:
- CRISPR-Cas9 gene editing represents a significant therapeutic advance for genetic muscular dystrophies.
- This technology holds promise for a curative approach to these debilitating muscle diseases.
- Further research and clinical application of CRISPR-Cas9 are warranted.
Related Concept Videos
CRISPR
57.2K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.2K
CRISPR/Cas9 Genome Editing
1.4K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.4K
Satellite Stem Cells and Muscular Dystrophy
2.2K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.2K
CRISPR and crRNAs
18.5K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.5K
Homologous Recombination
61.9K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
61.9K

